Profund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Sell |
|
|||||
|
2025
Q1 | $260K | Buy |
|
|||||
|
2024
Q4 | $260K | Sell |
|
|||||
|
2024
Q3 | $292K | Sell |
|
|||||
|
2024
Q2 | $266K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $221K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $229K | Sell |
|
|||||
|
2021
Q3 | $230K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $203K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $797K | Sell |
|
|||||
|
2019
Q1 | $957K | Buy |
|
|||||
|
2018
Q4 | $949K | Sell |
|
|||||
|
2018
Q3 | $2.97M | Sell |
|
|||||
|
2018
Q2 | $2.25M | Buy |
|
|||||
|
2018
Q1 | $1.76M | Buy |
|
|||||
|
2017
Q4 | $1.37M | Sell |
|
|||||
|
2017
Q3 | $1.49M | Buy |
|
|||||
|
2017
Q2 | $1.25M | Sell |
|
|||||
|
2017
Q1 | $1.09M | Sell |
|
|||||
|
2016
Q4 | $1.14M | Sell |
|
|||||
|
2016
Q3 | $1.22M | Buy |
|
|||||
|
2016
Q2 | $232K | Sell |
|
|||||
|
2016
Q1 | $220K | Sell |
|
|||||
|
2015
Q4 | $316K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $354K | Sell |
|
|||||
|
2015
Q1 | $429K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $329K | Buy |
|
|||||
|
2014
Q1 | $241K | Sell |
|
|||||
|
2013
Q4 | $321K | Buy |
|